NCT03024788

Brief Summary

Study of the correlation between AGEsP and HbA1c and diabetic retinopathy prevalence: determination of cut-off value of AGEsP and HbA1c in type 2 diabetes diagnosis in China

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
6,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

January 11, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 19, 2017

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

May 8, 2017

Status Verified

May 1, 2017

Enrollment Period

3.4 years

First QC Date

January 11, 2017

Last Update Submit

May 3, 2017

Conditions

Type II Diabetes

Keywords

Glycosylated haemoglobinadvanced glycation end products

Outcome Measures

Primary Outcomes (1)

  • prevalence of retinopathy

    the prevalence of retinopathy in different AGEsP and HbA1c levels

    3 years

Secondary Outcomes (1)

  • incidence of retinopathy

    3 years

Interventions

syringe, fundus camera etcDEVICE

Physical examination, fundus examination, blood and urine samples collection

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Chinese natural population

You may qualify if:

  • \~70 years old;
  • Volunteer to participate in this study and signed informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Syringes

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director physician

Study Record Dates

First Submitted

January 11, 2017

First Posted

January 19, 2017

Study Start

January 1, 2017

Primary Completion

June 1, 2020

Study Completion

December 1, 2020

Last Updated

May 8, 2017

Record last verified: 2017-05